Hearing preservation cochlear implantation in children: The HEARRING Group consensus and practice guide

Gunesh Rajan1, Dayse Tavora-Vieira1, Wolf-Dieter Baumgartner2

  • 1a Department of Otolaryngology, Head and Neck Surgery , School of Surgery, University of Western Australia , Murdoch , Australia.

Insights

Hearing preservation cochlear implantation (HPCI) is a safe and effective option for children, even with partial deafness (PD). Early detection and multidisciplinary assessment are crucial for successful HPCI outcomes.

Area of Science:

  • Otolaryngology
  • Audiology
  • Pediatric Medicine

Background:

  • Current evidence and practice regarding pediatric cochlear implantation, focusing on hearing preservation.
  • The need for updated guidelines for multidisciplinary teams performing hearing preservation cochlear implantation (HPCI).
  • Addressing the specific challenges of HPCI in children with symptomatic partial deafness (PD) for electric-acoustic stimulation (EAS).

Framework:

  • Consensus statement developed by the HEARRING group.
  • Review of current evidence and clinical practices for HPCI in children.
  • Focus on three key questions: candidacy, assessment, and management.

Implementation:

  • Guidelines for identifying suitable candidates for HPCI.
  • Protocols for comprehensive pre-implantation assessment in children.
  • Recommendations for surgical timing, particularly with Med-El Flex electrode arrays.

Implications:

  • HPCI is a safe and reliable treatment for all children undergoing cochlear implantation, regardless of residual hearing.
  • Early detection and multidisciplinary assessment are vital for identifying pediatric candidates for HPCI.
  • Timely HPCI intervention is recommended for children with symptomatic PD to maximize benefits.
Abstract